FOXA2 promotes the occurrence and development of osteosarcoma cells by regulating ferroptosis through the Rheb/mTOR axis

Read full text Summarise with VIRAT
Authors: Jiahao Xia, Jingbin Wu, Yuan Tao, Zhongxing Wan, Weihao Duan, Yiping Weng
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Osteosarcoma (OS) is a prevalent and aggressive primary carcinoma of the bone that predominantly influences children and adolescents. Inadequate therapeutic strategies have hindered improvements in patient survival. The forkhead box transcription factor FOXA2 plays a role in metabolic homeostasis and tumor progression. However, its association with OS remains underexplored. METHODS: Firstly, we investigated the expression of FOXA2 in OS cells and in OS tissue samples from patients at different clinical stages using western blot and immunohistochemistry (IHC). Analysis of the R2 database revealed the association between FOXA2 and the prognosis of OS patients. Subsequently, a series of functional experiments confirmed the biological behaviors of OS caused by FOXA2. Furthermore, through western blot, chromatin immunoprecipitation (ChIP), dual-luciferase reporter assays, and other experiments, we identified a key underlying molecular mechanisms. RESULTS: The present study determined that FOXA2 is overexpressed in OS cells and tissues, affecting OS patient prognosis. FOXA2 knockdownin functional experiments on OS cells attenuated their proliferation and migration while promoting ferroptosis, thereby offering an alternative intervention for OS as a form of programmed cell death. Upregulated Rheb restored the proliferation and migration in FOXA2 knockdown OS cells by facilitating ferroptosis induced by the mTOR pathway. CONCLUSIONS: The study results corroborated that FOXA2 suppresses ferroptosis via the Rheb/mTOR axis, stimulating OS cell proliferation and migration. Targeting the FOXA2/Rheb/mTOR axis and clarifying the fundamental mechanisms are thus crucial for the clinical OS treatment.

Fields of Study & Subjects

Ferroptosis and cancer prognosis Sarcoma Diagnosis and Treatment Bone Tumor Diagnosis and Treatments

Publication details

Journal / source
World Journal of Surgical Oncology
Volume
24
Issue
1
Pages
198
Publication date
31 March 2026
Language
EN